Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics plc - American Depositary Shares
(NQ:
BCYC
)
3.730
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bicycle Therapeutics plc - American Depositary Shares
< Previous
1
2
3
4
5
Next >
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
July 30, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 21, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
April 30, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
April 21, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
April 20, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
March 18, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
March 17, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
February 03, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
January 12, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
December 16, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
October 30, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
September 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
August 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
May 22, 2025
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 01, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments
March 27, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
February 25, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
January 13, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 09, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
